NZX Financial News
Data-driven earnings reports and market analysis
Auto-generated financial articles from structured NZX data. Every number is sourced directly from company announcements and public filings — no speculation, no opinion, just data.
New Zealand Rural Land Company Reports Net Profit Surge to $39.7M on Strong FY2022 Performance
Net profit more than doubled year-on-year, though revenue data for the current period remains unavailable.
New Zealand Rural Land Company Reports Sharp Profit Decline in FY2023 Amid Revenue Growth
Net profit fell 73% year-on-year to $10.9M despite revenue increasing to $15.3M, signalling a margin compression in the real estate investment company's portfolio.
New Zealand Rural Land Company Reports Net Profit Surge to $23.1M on Horticultural Expansion
Net profit more than doubles year-on-year despite flat underlying earnings, driven by property revaluations and acquisition activity.
TradeWindow Holdings Reports 143.8% Revenue Growth Amid Continued Losses in FY2022
Revenue surged significantly year-on-year, though the company remained unprofitable as operating losses widened.
TradeWindow Holdings Reports 25.6% Revenue Growth Amid Continued Losses in FY2023
Management guidance suggests the company is targeting a path to EBITDA breakeven by end-FY25, though the industrials firm remains unprofitable.
TradeWindow Holdings Reports 26.5% Revenue Growth Despite Continued Losses in FY2024
Management guidance suggests a path toward EBITDA breakeven by March 2025, though the company remains unprofitable.
TradeWindow Holdings Reports FY2025 Results: Revenue Growth Accelerates Amid Continued Losses
Despite a 29% revenue increase to $8.0M, TradeWindow Holdings remains unprofitable, though losses have narrowed significantly year-on-year.
RTO Limited Reports Dramatic Revenue Surge in FY2019 Amid Continued Losses
Information technology company achieves 690% revenue growth to $1.3M, though net losses persist at $585K.
RTO Limited Reports Full-Year FY2021 Results: Revenue Declines 10.8% Amid Continued Losses
Revenue contraction and persistent net losses suggest RTO Limited faced significant operational headwinds during FY2021, with the company reporting a $427K net loss despite year-on-year profit improvement.
RTO Limited Reports Severe Revenue Contraction in FY2022 as Company Pursues Reverse Takeover Strategy
The information technology company's revenue collapsed 71.1% to $39K in FY2022, while the company actively seeks acquisition opportunities through a reverse takeover transaction.
RTO Limited Reports Severe Revenue Contraction in FY2023
Dramatic 77% revenue decline to $9K reflects continued operational challenges for the IT services company.
RTO Limited Reports Full-Year FY2024 Results: Revenue Doubles While Losses Narrow
Revenue growth of 105% masks a company navigating significant operational challenges, with net losses persisting despite improved year-on-year performance.
RTO Limited Reports Dramatic Revenue Expansion Amid Continued Losses in FY2025
Substantial year-on-year revenue growth masks ongoing profitability challenges for the IT sector company.
Rua Bioscience Reports Widening Losses in FY2021 as Product Commercialisation Remains on Horizon
The healthcare company's net loss deteriorated significantly year-on-year, with regulatory pathways still pending ahead of anticipated 2022 product launch.
Rua Bioscience Reports Sharp Revenue Decline to $254K in FY2022, Though Net Profit Swings to Positive
Biotech firm's revenue contracted 29% year-on-year, though profitability metrics improved significantly from prior-year losses.
Rua Bioscience Reports Dramatic Revenue Acceleration in FY2023, Though Profitability Data Unavailable
Bioscience company's FY2023 revenue surged 1377.5% year-on-year, though underlying profit metrics remain undisclosed.
Rua Bioscience Reports Severe Revenue Contraction in FY2024 Amid Restructuring Phase
Management signals potential recovery ahead after July 2024 sales exceed full-year revenue.
Rua Bioscience Reports Dramatic Revenue Surge Amid Continued Losses in FY2025
Healthcare biotech firm achieves 490% revenue growth but remains unprofitable as losses narrow significantly year-on-year.
Enprise Group Limited Reports Full-Year FY2019 Results: Revenue Declines 23.3% to $6.8M
Enprise Group's FY2019 performance indicates a significant contraction in revenue alongside a net loss, suggesting operational headwinds in the IT services sector.
Enprise Group Limited Reports Full-Year FY2020 Results: Revenue Surges 83.5% as Company Returns to Profitability
Enprise Group swung to a substantial net profit in FY2020 after the prior year loss, with revenue growth of 83.5% suggesting significant operational expansion during the period.
Enprise Group Limited Reports Full-Year FY2021 Results: Revenue Surges 29.7% Amid Profit Decline
Strong top-line growth masks a significant year-on-year contraction in net profitability for the IT services provider.
Enprise Group Reports 16.1% Revenue Growth in FY2022, But Swings to $2.1M Net Loss
Despite strong top-line expansion, the IT services provider moved into loss-making territory as profitability deteriorated sharply year-on-year.
Enprise Group Limited Reports Full-Year FY2023 Results: Revenue Growth Masks Widening Losses
Revenue increased 10.2% to $20.7M, but net losses deteriorated significantly to -$11.8M, representing a concerning reversal in profitability trajectory.
Enprise Group Limited Reports Full-Year FY2024 Results: Revenue Up 6.5% as Profitability Swings to Positive
Net profit returned to positive territory with an 100.8% improvement year-on-year, though governance metrics remain a concern.
Data sourced from publicly available records. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.